Sensus Healthcare (SRTS) Competitors

Sensus Healthcare (NASDAQ:SRTS) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking.

Is SRTS or TCMD more profitable?

Sensus Healthcare has a net margin of 15.90% compared to Tactile Systems Technology's net margin of 5.79%. Sensus Healthcare's return on equity of 12.60% beat Tactile Systems Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	15.90%	12.60%	11.38%
Tactile Systems Technology	5.79%	9.37%	6.75%

Do insiders and institutionals hold more shares of SRTS or TCMD?

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 9.4% of Sensus Healthcare shares are held by company insiders. Comparatively, 1.0% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has better valuation and earnings, SRTS or TCMD?

Tactile Systems Technology has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$41.81M	1.90	$6.65M	$0.40	12.03
Tactile Systems Technology	$292.98M	1.09	$28.51M	$0.70	19.27

Which has more volatility and risk, SRTS or TCMD?

Sensus Healthcare has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500.

Do analysts rate SRTS or TCMD?

Sensus Healthcare presently has a consensus target price of $13.00, suggesting a potential upside of 170.27%. Tactile Systems Technology has a consensus target price of $18.00, suggesting a potential upside of 33.43%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Sensus Healthcare is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Tactile Systems Technology	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer SRTS or TCMD?

In the previous week, Tactile Systems Technology had 7 more articles in the media than Sensus Healthcare. MarketBeat recorded 7 mentions for Tactile Systems Technology and 0 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.43 beat Tactile Systems Technology's score of 0.97 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Positive
Tactile Systems Technology	Positive

Does the MarketBeat Community prefer SRTS or TCMD?

Tactile Systems Technology received 193 more outperform votes than Sensus Healthcare when rated by MarketBeat users. Likewise, 70.13% of users gave Tactile Systems Technology an outperform vote while only 68.77% of users gave Sensus Healthcare an outperform vote.

Company	Underperform	Outperform
Sensus Healthcare	Outperform Votes 185 68.77%	Underperform Votes 84 31.23%
Tactile Systems Technology	Outperform Votes 378 70.13%	Underperform Votes 161 29.87%

Summary

Sensus Healthcare beats Tactile Systems Technology on 11 of the 19 factors compared between the two stocks.